Jun 16, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
FDA's Draft Guidance: Methodological Challenges Of Suicidality Assessment
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2312156" data-attributes="member: 124445"><p>Responding to the growing importance of suicidality assessment in clinical trials, the Food and Drug Administration has released the first draft of a proposed guidance on the issue, "Suicidality: Prospective Assessment of Occurrence in Clinical Trials" in which the FDA establishes its "current thinking" regarding the importance of suicidality assessment in drug trials, and proposes general principles to best accomplish this assessment during drug development. "ISCTM hopes to facilitate a productive conversation regarding best practices in existing and future clinical trials...<a href="http://feedads.g.doubleclick.net/~a/UgUdAmi-Zh7Z8dKVcvyAXGeK5_o/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/UgUdAmi-Zh7Z8dKVcvyAXGeK5_o/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/UgUdAmi-Zh7Z8dKVcvyAXGeK5_o/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/UgUdAmi-Zh7Z8dKVcvyAXGeK5_o/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/ESM0dM2a2eM" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/ESM0dM2a2eM/3JZ2" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2312156, member: 124445"] Responding to the growing importance of suicidality assessment in clinical trials, the Food and Drug Administration has released the first draft of a proposed guidance on the issue, "Suicidality: Prospective Assessment of Occurrence in Clinical Trials" in which the FDA establishes its "current thinking" regarding the importance of suicidality assessment in drug trials, and proposes general principles to best accomplish this assessment during drug development. "ISCTM hopes to facilitate a productive conversation regarding best practices in existing and future clinical trials...[URL="http://feedads.g.doubleclick.net/~a/UgUdAmi-Zh7Z8dKVcvyAXGeK5_o/0/da"][IMG]http://feedads.g.doubleclick.net/~a/UgUdAmi-Zh7Z8dKVcvyAXGeK5_o/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/UgUdAmi-Zh7Z8dKVcvyAXGeK5_o/1/da"][IMG]http://feedads.g.doubleclick.net/~a/UgUdAmi-Zh7Z8dKVcvyAXGeK5_o/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/ESM0dM2a2eM[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/ESM0dM2a2eM/3JZ2]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top